# EDGAR Filing Document

**Accession Number:** 0002048519
**File Stem:** 0001628280-26-034785
**Filing Date:** 2026-5
**Character Count:** 131077
**Document Hash:** c858f6712968471a9f5eb07031950415
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-034785.hdr.sgml**: 20260514

**ACCESSION NUMBER**: 0001628280-26-034785

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 85

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260514

**DATE AS OF CHANGE**: 20260514

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aebi Schmidt Holding AG
- **CENTRAL INDEX KEY:** 0002048519
- **STANDARD INDUSTRIAL CLASSIFICATION:** CONSTRUCTION MACHINERY & EQUIP [3531]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** V8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42663
- **FILM NUMBER:** 26975767

**BUSINESS ADDRESS:**
- **STREET 1:** SCHULSTRASSE 4
- **CITY:** FRAUENFELD
- **STATE:** V8
- **ZIP:** 8500
- **BUSINESS PHONE:** 41 (44) 308 5855

**MAIL ADDRESS:**
- **STREET 1:** SCHULSTRASSE 4
- **CITY:** FRAUENFELD
- **STATE:** V8
- **ZIP:** 8500

?xml version='1.0' encoding='ASCII'? aebi-20260331

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

(Mark One)

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended March 31, 2026**

**or**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.**

**Commission File Number: 001-42663**

**Aebi Schmidt Holding AG**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Switzerland** | **Not Applicable** |
| (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer<br>Identification Number) |
| **Schulstrasse 4**<br>**CH-8500 Frauenfeld, Switzerland** (Address of Principal Executive Offices) | **8500** (Zip Code)  |

---

**+41 44-308-5800**

(Registrant's telephone number, including

area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s): Name of each exchange on which registered <br> <u>Common Stock</u> <u>AEBI</u> <u>The NASDAQ Stock Market LLC</u>

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the

Exchange Act). ☐ Yes ☒ No

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

<u>Class</u> <u>Outstanding as of May 8, 2026</u> <br> Common Stock 77,506,125 shares

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

**FORWARD-LOOKING STATEMENTS**

This Quarterly Report on Form 10-Q (this "Quarterly Report") contains some statements that are not historical facts. These statements are called "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements involve important known and unknown risks, uncertainties and other factors and generally can be identified by phrases using "estimate," "anticipate," "believe," "project," "expect," "intend," "predict," "potential," "future," "may," "will," "should" or similar expressions or words. Aebi Schmidt Holding AG's ("Aebi Schmidt," the "Company," "we," "us" or "our") future results, performance or achievements may differ materially from the results, performance or achievements discussed in the forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict with regard to timing, extent, likelihood and degree of occurrence. Therefore, actual results and outcomes may materially differ from what may be expressed or forecasted in such forward-looking statements.

Factors that might cause future results to differ materially from those projected in the forward-looking statements include, but are not limited to, those described in the section titled "*Risk Factors*" in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025, as well as risk factors that we have discussed in previous public reports and other documents filed with the Securities and Exchange Commission (the "SEC"). Such risk factors include the primary risks our management believes could materially affect the potential results described by forward-looking statements contained in this Quarterly Report. However, these risks may not be the only risks we face. Our business, operations and financial performance could also be affected by additional factors that are not presently known to us or that we currently consider to be immaterial to our operations. In addition, new risk factors may emerge from time to time that may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, although we believe that the forward-looking statements contained in this Quarterly Report are reasonable, we cannot provide you with any guarantee that the results described in those forward-looking statements will be achieved. All forward-looking statements in this Quarterly Report are expressly qualified in their entirety by the cautionary statements contained in this section, and investors should not place undue reliance on forward-looking statements as a prediction of actual results. The Company undertakes no obligation to update or revise any forward-looking statements to reflect developments or information obtained after the date this Quarterly Report is filed with the SEC, except as required by applicable law.

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

**INDEX**

**PART I—FINANCIAL INFORMATION**

---

| | | |
|:---|:---|:---|
| [Item 1.](#i97252dd9126049278d8da9d2f8bc1fe5_19) | <u>[Financial Statements.](#i97252dd9126049278d8da9d2f8bc1fe5_19)</u> | [3](#i97252dd9126049278d8da9d2f8bc1fe5_19) |
| <u>[CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)](#i97252dd9126049278d8da9d2f8bc1fe5_22)</u> | <u>[CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)](#i97252dd9126049278d8da9d2f8bc1fe5_22)</u> | [3](#i97252dd9126049278d8da9d2f8bc1fe5_22) |
| <u>[CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)](#i97252dd9126049278d8da9d2f8bc1fe5_25)</u> | <u>[CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)](#i97252dd9126049278d8da9d2f8bc1fe5_25)</u> | [4](#i97252dd9126049278d8da9d2f8bc1fe5_25) |
| <u>[CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)](#i97252dd9126049278d8da9d2f8bc1fe5_28)</u> | <u>[CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)](#i97252dd9126049278d8da9d2f8bc1fe5_28)</u> | [5](#i97252dd9126049278d8da9d2f8bc1fe5_28) |
| <u>[CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited)](#i97252dd9126049278d8da9d2f8bc1fe5_31)</u> | <u>[CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited)](#i97252dd9126049278d8da9d2f8bc1fe5_31)</u> | [6](#i97252dd9126049278d8da9d2f8bc1fe5_31) |
| <u>[CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)](#i97252dd9126049278d8da9d2f8bc1fe5_34)</u> | <u>[CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)](#i97252dd9126049278d8da9d2f8bc1fe5_34)</u> | [7](#i97252dd9126049278d8da9d2f8bc1fe5_34) |
| <u>[NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS](#i97252dd9126049278d8da9d2f8bc1fe5_37)</u> | <u>[NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS](#i97252dd9126049278d8da9d2f8bc1fe5_37)</u> | [8](#i97252dd9126049278d8da9d2f8bc1fe5_37) |
| &nbsp;&nbsp;&nbsp;<u>[NOTE 1 – NATURE OF OPERATIONS AND BASIS OF PRESENTATION](#i97252dd9126049278d8da9d2f8bc1fe5_40)</u> | &nbsp;&nbsp;&nbsp;<u>[NOTE 1 – NATURE OF OPERATIONS AND BASIS OF PRESENTATION](#i97252dd9126049278d8da9d2f8bc1fe5_40)</u> | [8](#i97252dd9126049278d8da9d2f8bc1fe5_40) |
| &nbsp;&nbsp;&nbsp;<u>[NOTE 2 – REVENUE](#i97252dd9126049278d8da9d2f8bc1fe5_43)</u> | &nbsp;&nbsp;&nbsp;<u>[NOTE 2 – REVENUE](#i97252dd9126049278d8da9d2f8bc1fe5_43)</u> | [10](#i97252dd9126049278d8da9d2f8bc1fe5_43) |
| &nbsp;&nbsp;&nbsp;<u>[NOTE 3 – INVENTORIES](#i97252dd9126049278d8da9d2f8bc1fe5_46)</u> | &nbsp;&nbsp;&nbsp;<u>[NOTE 3 – INVENTORIES](#i97252dd9126049278d8da9d2f8bc1fe5_46)</u> | [11](#i97252dd9126049278d8da9d2f8bc1fe5_46) |
| &nbsp;&nbsp;&nbsp;<u>[NOTE 4 – PROPERTY, PLANT AND EQUIPMENT](#i97252dd9126049278d8da9d2f8bc1fe5_52)</u> | &nbsp;&nbsp;&nbsp;<u>[NOTE 4 – PROPERTY, PLANT AND EQUIPMENT](#i97252dd9126049278d8da9d2f8bc1fe5_52)</u> | [12](#i97252dd9126049278d8da9d2f8bc1fe5_52) |
| &nbsp;&nbsp;&nbsp;<u>[NOTE 5 – LEASES](#i97252dd9126049278d8da9d2f8bc1fe5_55)</u> | &nbsp;&nbsp;&nbsp;<u>[NOTE 5 – LEASES](#i97252dd9126049278d8da9d2f8bc1fe5_55)</u> | [12](#i97252dd9126049278d8da9d2f8bc1fe5_55) |
| &nbsp;&nbsp;&nbsp;<u>[NOTE 6 – INCOME TAXES](#i97252dd9126049278d8da9d2f8bc1fe5_58)</u> | &nbsp;&nbsp;&nbsp;<u>[NOTE 6 – INCOME TAXES](#i97252dd9126049278d8da9d2f8bc1fe5_58)</u> | [13](#i97252dd9126049278d8da9d2f8bc1fe5_58) |
| &nbsp;&nbsp;&nbsp;<u>[NOTE 7 – COMMITMENTS AND CONTINGENT LIABILITIES](#i97252dd9126049278d8da9d2f8bc1fe5_61)</u> | &nbsp;&nbsp;&nbsp;<u>[NOTE 7 – COMMITMENTS AND CONTINGENT LIABILITIES](#i97252dd9126049278d8da9d2f8bc1fe5_61)</u> | [14](#i97252dd9126049278d8da9d2f8bc1fe5_61) |
| &nbsp;&nbsp;&nbsp;<u>[NOTE 8 – DEFINED BENEFIT PENSION PLANS](#i97252dd9126049278d8da9d2f8bc1fe5_64)</u> | &nbsp;&nbsp;&nbsp;<u>[NOTE 8 – DEFINED BENEFIT PENSION PLANS](#i97252dd9126049278d8da9d2f8bc1fe5_64)</u> | [14](#i97252dd9126049278d8da9d2f8bc1fe5_64) |
| &nbsp;&nbsp;&nbsp;<u>[NOTE 9 – DEBT](#i97252dd9126049278d8da9d2f8bc1fe5_67)</u> | &nbsp;&nbsp;&nbsp;<u>[NOTE 9 – DEBT](#i97252dd9126049278d8da9d2f8bc1fe5_67)</u> | [15](#i97252dd9126049278d8da9d2f8bc1fe5_67) |
| &nbsp;&nbsp;&nbsp;<u>[NOTE 10 – ACCUMULATED OTHER COMPREHENSIVE INCOME](#i97252dd9126049278d8da9d2f8bc1fe5_70)</u> | &nbsp;&nbsp;&nbsp;<u>[NOTE 10 – ACCUMULATED OTHER COMPREHENSIVE INCOME](#i97252dd9126049278d8da9d2f8bc1fe5_70)</u> | [16](#i97252dd9126049278d8da9d2f8bc1fe5_70) |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[NOTE 11 – EARNINGS PER SHARE](#i97252dd9126049278d8da9d2f8bc1fe5_76)</u> | &nbsp;&nbsp;&nbsp;&nbsp;<u>[NOTE 11 – EARNINGS PER SHARE](#i97252dd9126049278d8da9d2f8bc1fe5_76)</u> | [16](#i97252dd9126049278d8da9d2f8bc1fe5_76) |
| &nbsp;&nbsp;&nbsp;<u>[NOTE 12 – BUSINESS COMBINATION](#i97252dd9126049278d8da9d2f8bc1fe5_79)</u> | &nbsp;&nbsp;&nbsp;<u>[NOTE 12 – BUSINESS COMBINATION](#i97252dd9126049278d8da9d2f8bc1fe5_79)</u> | [17](#i97252dd9126049278d8da9d2f8bc1fe5_79) |
| &nbsp;&nbsp;&nbsp;<u>[NOTE 13 – SEGMENTS](#i97252dd9126049278d8da9d2f8bc1fe5_82)</u> | &nbsp;&nbsp;&nbsp;<u>[NOTE 13 – SEGMENTS](#i97252dd9126049278d8da9d2f8bc1fe5_82)</u> | [20](#i97252dd9126049278d8da9d2f8bc1fe5_82) |
| [Item 2.](#i97252dd9126049278d8da9d2f8bc1fe5_88) | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i97252dd9126049278d8da9d2f8bc1fe5_88)</u> | [24](#i97252dd9126049278d8da9d2f8bc1fe5_88) |
| [Item 3.](#i97252dd9126049278d8da9d2f8bc1fe5_124) | <u>[Quantitative and Qualitative Disclosure About Market Risk](#i97252dd9126049278d8da9d2f8bc1fe5_124)</u> | [33](#i97252dd9126049278d8da9d2f8bc1fe5_124) |
| [Item 4.](#i97252dd9126049278d8da9d2f8bc1fe5_127) | <u>[Controls and Procedures](#i97252dd9126049278d8da9d2f8bc1fe5_127)</u> | [33](#i97252dd9126049278d8da9d2f8bc1fe5_127) |
| **PART II—OTHER INFORMATION** | **PART II—OTHER INFORMATION** | **PART II—OTHER INFORMATION** |
| [Item 1.](#i97252dd9126049278d8da9d2f8bc1fe5_133) | <u>[Legal Proceedings](#i97252dd9126049278d8da9d2f8bc1fe5_133)</u> | [35](#i97252dd9126049278d8da9d2f8bc1fe5_133) |
| [Item 1A.](#i97252dd9126049278d8da9d2f8bc1fe5_136) | <u>[Risk Factors](#i97252dd9126049278d8da9d2f8bc1fe5_136)</u> | [35](#i97252dd9126049278d8da9d2f8bc1fe5_136) |
| [Item 2.](#i97252dd9126049278d8da9d2f8bc1fe5_139) | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i97252dd9126049278d8da9d2f8bc1fe5_139)</u> | [35](#i97252dd9126049278d8da9d2f8bc1fe5_139) |
| [Item 5.](#i97252dd9126049278d8da9d2f8bc1fe5_142) | <u>[Other Information](#i97252dd9126049278d8da9d2f8bc1fe5_142)</u> | [35](#i97252dd9126049278d8da9d2f8bc1fe5_142) |
| [Item 6.](#i97252dd9126049278d8da9d2f8bc1fe5_145) | <u>[Exhibits](#i97252dd9126049278d8da9d2f8bc1fe5_145)</u> | [36](#i97252dd9126049278d8da9d2f8bc1fe5_145) |
| <u>[Signatures](#i97252dd9126049278d8da9d2f8bc1fe5_148)</u> | <u>[Signatures](#i97252dd9126049278d8da9d2f8bc1fe5_148)</u> | [37](#i97252dd9126049278d8da9d2f8bc1fe5_148) |

---

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

**PART I – FINANCIAL INFORMATION**

**Item 1. Financial Statements.**

**AEBI SCHMIDT HOLDING AG AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)**

(In thousands, except share data)

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| **Assets** | | |
| **Current assets:** | | |
| Cash and cash equivalents | $115886 | $98512 |
| Accounts receivable, less allowance for credit losses of $248 and $505 | 271241 | 310755 |
| Contract assets | 81430 | 82342 |
| Inventories | 379186 | 346423 |
| Prepaid expense and other current assets | 42553 | 39698 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total current assets** | 890296 | 877730 |
| **Property, plant and equipment, net** | 162626 | 167899 |
| **Goodwill** | 403681 | 403147 |
| **Intangible assets, net** | 326532 | 334726 |
| **Deferred tax assets** | 5733 | 5910 |
| **Right of use assets operating leases** | 166166 | 167162 |
| **Other assets** | 52081 | 51705 |
| &nbsp;&nbsp;&nbsp;&nbsp;**TOTAL ASSETS** | $2007115 | $2008279 |
| **LIABILITIES AND EQUITY** |  |  |
| **Current liabilities:** |  |  |
| Accounts payable | $201927 | $234642 |
| Accrued warranty | 17148 | 17669 |
| Accrued compensation and related taxes | 32900 | 36957 |
| Contract liabilities | 24222 | 19856 |
| Operating lease liabilities | 18318 | 18856 |
| Other current liabilities and accrued expenses | 86010 | 86366 |
| Current portion of long-term debt | 67911 | 46908 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total current liabilities** | 448436 | 461254 |
| **Other non-current liabilities** | 14822 | 15308 |
| **Long-term operating lease liabilities** | 144839 | 144401 |
| **Long-term debt, less current portion** | 502745 | 488949 |
| **Long-term loans from shareholders** | 58213 | 59101 |
| **Deferred tax liabilities** | 23367 | 24315 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities** | 1192422 | 1193328 |
| **Commitments and contingent liabilities** |  |  |
| **Shareholders' Equity:** |  |  |
| Common stock, $1.00 par value: 79,300,000 and 79,300,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; and 77,157,983 and 76,998,754 shares outstanding as of March 31, 2026 and December 31, 2025, respectively. | 77158 | 76999 |
| Additional paid-in capital | 652736 | 652425 |
| Treasury shares, at cost | (257) | (257) |
| Retained earnings | 56300 | 57551 |
| Accumulated other comprehensive income | 28730 | 28183 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Shareholders' equity attributable to Aebi Schmidt Holding AG** | 814667 | 814901 |
| Non-controlling interest | 26 | 50 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Shareholders' equity** | 814693 | 814951 |
| **TOTAL LIABILITIES AND EQUITY** | $2007115 | $2008279 |

---

See accompanying Notes to Condensed Consolidated Financial Statements

(Reflects the retrospective application of the 1-for-7.5 forward stock split effective July 1, 2025, see Note 1 - Nature of Operations and Basis of Presentation)

Page 3 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

**AEBI SCHMIDT HOLDING AG AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)**

(In thousands, except per share data)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Sales | $455545 | $249186 |
| Cost of products sold | (368156) | (195880) |
| **Gross profit** | 87389 | 53306 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;Research and development | (6701) | (4627) |
| &nbsp;&nbsp;Selling, general and administrative | (58547) | (30724) |
| &nbsp;&nbsp;Amortization of purchased intangibles | (8052) | (3574) |
| &nbsp;&nbsp;Other operating income | 1279 | 13 |
| Total operating expenses | (72021) | (38912) |
| **Operating income** | 15368 | 14394 |
| Other income (expense): |  |  |
| &nbsp;&nbsp;Interest expense | (11350) | (6503) |
| &nbsp;&nbsp;Other income (expense) | (2859) | (5042) |
| Total other expense | (14209) | (11545) |
| Income before income taxes | 1159 | 2849 |
| Income tax (expense) benefit | (488) | (787) |
| Net income | 671 | 2062 |
| Less: Net income (loss) attributable to non-controlling interest | (24) | (13) |
| **Net income attributable to Aebi Schmidt Holding AG** | $**695** | $**2075** |
| **Earnings per share** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic earnings per share | $0.01 | $0.05 |
| &nbsp;&nbsp;&nbsp;&nbsp; Diluted earnings per share | $0.01 | $0.05 |
| Basic weighted average common shares outstanding | 77106 | 40352 |
| Diluted weighted average common shares outstanding | 77406 | 40352 |

---

See accompanying Notes to Condensed Consolidated Financial Statements.

(Reflects the retrospective application of the 1-for-7.5 forward stock split effective July 1, 2025, see Note 1 - Nature of Operations and Basis of Presentation)

Page 4 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

**AEBI SCHMIDT HOLDING AG AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)**

(In thousands)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Net income | $671 | $2062 |
| **Other comprehensive income:** |  |  |
| &nbsp;&nbsp;Foreign currency translation adjustments | 732 | 181 |
| &nbsp;&nbsp;Pension benefit (loss), net of tax | (185) | 3986 |
| &nbsp;&nbsp;Other comprehensive income (loss), net of tax | 547 | 4167 |
| Comprehensive income | 1218 | 6229 |
| Less: Comprehensive income (loss) attributable to non-controlling interests | (24) | (13) |
| **Comprehensive income attributable to Aebi Schmidt Holding AG** | $1242 | $6242 |

---

See accompanying Notes to Condensed Consolidated Financial Statements.

(Reflects the retrospective application of the 1-for-7.5 forward stock split effective July 1, 2025, see Note 1 - Nature of Operations and Basis of Presentation)

Page 5 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

**AEBI SCHMIDT HOLDING AG AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited)**

(In thousands, except share data)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Number <br>of shares** | **Common <br>stock** | **Additional <br>Paid-in<br> Capital** | **Treasury<br> shares** | **Retained <br>earnings** | **Accumulated <br>Other <br>Comprehensive<br> Income** | **Total<br>Shareholders'<br> equity** | **Non-<br>controlling <br>interest** | **Total equity** |
| **Balance at January 1, 2026** | 76998754 | $76999 | $652425 | $(257) | $57551 | 28183 | $814901 | $50 | $814951 |
| Translation adjustments in the reporting period |  |  |  |  |  | 732 | 732 |  | 732 |
| Pension loss |  |  |  |  |  | (185) | (185) |  | (185) |
| Net income (loss) |  |  |  |  | 695 |  | 695 | (24) | 671 |
| Stock based compensation expense for 2025 Retention awards, net of cancellations |  |  | 239 |  |  |  | 239 |  | 239 |
| Issuance of common stock for Aebi Schmidt RSAs and RSUs, net of tax and cancellations | 159229 | 159 | 72 |  |  |  | 231 |  | 231 |
| Dividends declared ($0.025 per share) |  |  |  |  | (1946) |  | (1946) |  | (1946) |
| **Balance at March 31, 2026** | 77157983 | $77158 | $652736 | $(257) | $56300 | $28730 | $814667 | $26 | $814693 |

---

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Number** <br>**of shares** | **Common** <br>**stock** | **Additional**<br>**Paid-in Capital** | **Treasury**<br> **shares** | **Retained** <br>**earnings** | **Accumulated** <br>**Other** <br>**Comprehensive**<br> **Income** | **Total**<br> **Shareholders'**<br> **equity** | **Non-**<br>**controlling** <br>**interest** | **Total equity** |
| **Balance at January 1, 2025** | 40351680 | $40352 | $232281 | $(257) | $61247 | 31469 | $365092 | $83 | $365175 |
| Translation adjustments in the reporting period |  |  |  |  |  | 181 | 181 |  | 181 |
| Pension benefit |  |  |  |  |  | 3986 | 3986 |  | 3986 |
| Net income (loss) |  |  |  |  | 2075 |  | 2075 | (13) | 2062 |
| **Balance at March 31, 2025** | 40351680 | $40352 | $232281 | $(257) | $63322 | $35636 | $371334 | $70 | $371404 |

---

See accompanying Notes to Condensed Consolidated Financial Statements.

(Reflects the retrospective application of the 1-for-7.5 forward stock split effective July 1, 2025, see Note 1 - Nature of Operations and Basis of Presentation)

Page 6 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

**AEBI SCHMIDT HOLDING AG AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)**

(In thousands)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| Cash flows from operating activities: |  |  |
| Net income | $671 | $2062 |
| *Adjustments to reconcile net income to net cash provided by operating activities:* |  |  |
| &nbsp;&nbsp;Depreciation and amortization | 13803 | 6625 |
| &nbsp;&nbsp;Non-cash stock based compensation expense | 1003 |  |
| &nbsp;&nbsp;Foreign exchange (gains) losses on debt | 300 | 982 |
| &nbsp;&nbsp;Non-cash financing costs | 457 |  |
| &nbsp;&nbsp;Deferred taxes | 2355 | 1411 |
| &nbsp;&nbsp;Pension | (119) | (351) |
| &nbsp;&nbsp;Other, net | (9) | 400 |
| *Changes in operating assets and liabilities:* |  |  |
| &nbsp;&nbsp;Accounts receivable and contract assets | 38445 | 3793 |
| &nbsp;&nbsp;Inventories | (35777) | (23384) |
| &nbsp;&nbsp;Accounts payable | (32060) | (2465) |
| &nbsp;&nbsp;Contract liabilities | 4641 | (1276) |
| &nbsp;&nbsp;Income tax payable and receivable | (2364) | (748) |
| &nbsp;&nbsp;Accrued compensation and related taxes | (3206) |  |
| &nbsp;&nbsp;Other assets and liabilities | (5879) | (13610) |
| Net cash used in operating activities | (17739) | (26561) |
| *Cash flows from investing activities:* |  |  |
| &nbsp;&nbsp;Purchases of property, plant and equipment | (1934) | (3110) |
| &nbsp;&nbsp;Purchases of intangible assets |  | (10) |
| &nbsp;&nbsp;Proceeds from sale of property, plant and equipment | 879 | 12 |
| Net cash used in investing activities | (1055) | (3108) |
| *Cash flows from financing activities:* |  |  |
| &nbsp;&nbsp;Proceeds from issuance of debt | 41255 | 17395 |
| &nbsp;&nbsp;Deferred payments related to historical transactions | (916) | (5694) |
| &nbsp;&nbsp;Payment of finance lease principal | (338) | (259) |
| &nbsp;&nbsp;Payments of dividends | (2001) |  |
| &nbsp;&nbsp;Exercising and vesting of stock incentive awards | (1170) |  |
| Net cash provided by financing activities | 36830 | 11442 |
| Effect of exchange rate changes on cash and cash equivalents | (662) | 872 |
| Net increase (decrease) in cash and cash equivalents | 17374 | (17355) |
| Cash and cash equivalents at beginning of period | 98512 | 65173 |
| Cash and cash equivalents at end of period | $115886 | $47818 |
| Supplemental disclosures of cash flow information |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid during the period for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest | 10485 | 6453 |

---

See accompanying Notes to Condensed Consolidated Financial Statements**.**

(Reflects the retrospective application of the 1-for-7.5 forward stock split effective July 1, 2025, see Note 1 - Nature of Operations and Basis of Presentation)

Page 7 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

**AEBI SCHMIDT HOLDING AG AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(Dollar amounts in thousands, except per share data)

**NOTE 1 – NATURE OF OPERATIONS AND BASIS OF PRESENTATION**

As used herein, the term "the Company" or "Aebi Schmidt" refers to Aebi Schmidt Holding AG and its subsidiaries unless designated or identified otherwise.

***Nature of Operations***

The Company is a provider of innovative technical products for cleaning and clearing traffic areas as well as mowing green spaces in particularly challenging terrain. The range of products comprises vehicles, attachable and demountable devices for individual vehicle equipment as well as related services. In addition, the Company manufactures and assembles specialty vehicles for commercial and recreational applications, including walk-in vans, truck bodies for last-mile delivery, vocation-specific upfit solutions, and luxury motorhome chassis. It also offers replacement parts, repair, maintenance, and refurbishment services for these vehicles. Aebi Schmidt Holding AG covers the European and North American markets with its own sales organizations, while clients outside of these markets are served either directly by the exporting subsidiary or indirectly by the worldwide dealer network.

***The Shyft Transaction***

On December 16, 2024, the Company entered into an Agreement and Plan of Merger, dated as of December 16, 2024 (the "Merger Agreement"), by and among The Shyft Group, Inc., a Michigan corporation ("Shyft"), the Company, ASH US Group, LLC, a Delaware limited liability company and direct, wholly owned subsidiary of Aebi Schmidt ("Holdco"), and Badger Merger Sub, Inc., a Michigan corporation and direct, wholly owned subsidiary of Holdco ("Merger Sub"), pursuant to which, on the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub merged with and into Shyft (the "Merger", and the time at which the Merger is effective, the "Effective Time"), with Shyft surviving the Merger as a direct, wholly owned subsidiary of Holdco and as an indirect, wholly owned subsidiary of Aebi Schmidt (the transactions contemplated by the Merger Agreement, the "Transactions"). "Combined Company" refers to Aebi Schmidt as of and following the Effective Time.

At the Effective Time (July 1, 2025), each share of common stock, no par value, of Shyft ("Shyft Common Stock") that was issued and outstanding as of immediately prior to the Effective Time (other than any shares of Shyft Common Stock that are held as of immediately prior to the Effective Time by Holdco, Aebi Schmidt, Merger Sub or any of their respective subsidiaries) automatically converted into the right to receive 1.040166432 (the "Exchange Ratio") shares of fully paid and nonassessable shares of common stock, par value $1.00 per share, of Aebi Schmidt ("Aebi Schmidt Common Stock"), on the terms and subject to the conditions set forth in the Merger Agreement.

Immediately following the Effective Time, the holders of shares of Shyft Common Stock as of immediately prior to the Effective Time owned approximately 48% of the issued and outstanding shares of Aebi Schmidt Common Stock and the holders of shares of Aebi Schmidt Common Stock as of immediately prior to the Effective Time owned approximately 52% of the issued and outstanding shares of Aebi Schmidt Common Stock.

Immediately following the Effective Time, the Board of Directors of the Combined Company was composed of eleven members, six of whom were designated by Aebi Schmidt and five of whom were designated by Shyft. James A. Sharman, the Chairman of the Shyft Board of Directors as of immediately prior to the Effective Time, serves as the Chairman of the Board of Directors of the Combined Company (the "Combined Company Board") following the Effective Time. Barend Fruithof, current CEO of Aebi Schmidt, serves as Vice Chairman and Peter Spuhler, former Chairman of Aebi Schmidt, serves on the Combined Company Board.

The Merger is accounted for as a forward merger using the acquisition method of accounting, pursuant to Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 805, Business Combinations ("ASC 805"), with Aebi Schmidt treated as the legal and accounting acquirer and Shyft treated as the legal and accounting acquiree. For further information regarding the Shyft Transaction please refer to Note 12 – Business Combination.

Page 8 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

***Basis of Presentation and Consolidation***

The accompanying unaudited interim condensed consolidated financial statements include the accounts of Aebi Schmidt Holding AG and its subsidiaries and have been prepared in accordance with accounting principles generally accepted ("GAAP") in the United States ("U.S.") and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, certain information and disclosures required by GAAP for complete consolidated financial statements are not included herein. The results of operations for any interim period are not necessarily indicative of the results of operations for the full year. All inter-company transactions and balances have been eliminated. The accompanying unaudited interim condensed consolidated financial statements reflect all normal and recurring adjustments that are necessary for the fair statement of these interim financial statements. These interim financial statements should be read in conjunction with the audited consolidated financial statements and footnotes for the year ended December 31, 2025 included in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the Securities and Exchange Commission ("SEC") on March 19, 2026 (the "Form 10-K").

For a description of key accounting policies followed, refer to the footnotes to Aebi Schmidt Holding AG consolidated financial statements for the year ended December 31, 2025, included in our Form 10-K.

<u>Forward Stock Split.</u> On July 1, 2025, the Company effected a forward stock split of its issued and outstanding common stock, par value $1.00 per share, at a ratio of 1-for-7.5 (the "2025 Forward Stock Split"). Shares of common stock were proportionately increased.

All of the Company's historical share and per share information related to issued and outstanding common stock in these condensed consolidated financial statements have been adjusted, on a retroactive basis, to reflect the 2025 Forward Stock Split.

<u>Recently Issued Accounting Pronouncements Adopted.</u>

In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurements of Credit Losses for Accounts Receivable and Contract Assets ("ASU 2025-05"), which simplifies the estimation of credit losses on current accounts receivable and contract assets arising from transactions accounted for under ASC 606. The Company adopted ASU 2025-05 as of January 1, 2026 on a prospective basis. Adoption did not impact the Company's consolidated results of operations, financial position, or cash flows.

<u>Recently Issued Accounting Pronouncements Not Yet Adopted.</u> 

In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses (Subtopic 220-40) ("ASU 2024-03"). The ASU requires the disaggregated disclosure of specific expense categories, including purchases of inventory, employee compensation, depreciation, and amortization, within relevant income statement captions. This ASU also requires disclosure of the total amount of selling expenses along with the definition of selling expenses. The ASU is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Adoption of this ASU can either be applied prospectively to Consolidated Financial Statements issued for reporting periods after the effective date of this ASU or retrospectively to any or all prior periods presented in the Consolidated Financial Statements. Early adoption is also permitted. This ASU will result in the required additional disclosures being included in the Consolidated Financial Statements, once adopted. The Company is currently evaluating the impact of the adoption of ASU 2024-03 on the Consolidated Financial Statements.

In January 2025, the FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date ("ASU 2025-01"). ASU 2024-03 requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement. ASU 2024-03, as clarified by ASU 2025-01, is effective for the fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of these statements on the Consolidated Financial Statements.

In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40), Targeted Improvements to the Accounting for Internal-Use Software ("ASU 2025-06"). ASU 2025-06 clarified and modernizes the accounting for costs related to internal-use software. The amendments in ASU 2025-06 remove all references to project stages throughout Subtopic 350-40 and clarify the threshold entities apply to begin capitalizing costs.

Page 9 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

Entities must evaluate whether there is "significant development uncertainty," such as unresolved novel functionality or substantially revised performance requirements, before meeting this capitalization threshold. ASU 2025-06 is effective for the Company for fiscal years beginning after December 15, 2027 and interim periods within those fiscal years. The Company is currently evaluating the impact of adoption of ASU 2025-06 on the Consolidated Financial Statements.

In December 2025, the FASB issued ASU 2025-10, Government Grants - Accounting for Government Grants Received by Business Entities (Topic 832) ("ASU 2025-10"). ASU 2025-10 provides the guidance on the recognition, measurement, and presentation of government grants related to an asset or to income. ASU 2025-10 is effective for the Company for fiscal years beginning after December 15, 2028, including interim periods within those fiscal years. The Company is currently evaluating the impact of adoption of ASU 2025-10 on the Consolidated Financial Statements.

The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the Company's consolidated balance sheets, statements of income (loss) and comprehensive income (loss) and statements of cash flows.

**NOTE 2 – REVENUE**

<u>Contract Assets and Liabilities</u>

The tables below disclose changes in contract assets and liabilities for the three months ended March 31, 2026 and 2025.

---

| | | |
|:---|:---|:---|
| Contract Assets | **March 31,<br>2026** | **March 31,<br>2025** |
| Contract assets, beginning of period | $82342 | $24145 |
| Reclassification of contract assets to receivables, as the result of rights to consideration becoming unconditional | (55932) | (13018) |
| Contract assets recognized, net of reclassification to receivables | 55020 | 19941 |
| Contract assets, end of period | $81430 | $31068 |
| Contract Liabilities |  |  |
| Contract liabilities, beginning of period | $19856 | $20044 |
| Reclassification of contract liabilities to revenue, as the result of performance obligations satisfied | (3920) | (4637) |
| Cash received in advance and not recognized in revenue | 8286 | 4127 |
| Contract liabilities, end of period | $24222 | $19534 |

---

The aggregate amount of the transaction price allocated to remaining performance obligations in existing contracts that are yet to be completed in the North America and Europe and Rest of the World ("ROW") segments are $1,056,339 and $201,306 respectively, with substantially all revenue expected to be recognized within one year as of March 31, 2026.

For performance obligations that are satisfied over time, revenue is expected to be recognized over the period to complete the contract. For performance obligations that are satisfied at a point in time, revenue is expected to be recognized when the customer obtains control of the product, which is generally upon shipment from our facility. No amounts have been excluded from the transaction prices above related to the guidance on constraining estimates of variable consideration.

Page 10 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

In the following tables, revenue is disaggregated by primary geographical market and timing of revenue recognition. The tables also include a reconciliation of the disaggregated revenue with the reportable segments.

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31, 2026** | **Three Months Ended<br>March 31, 2026** | **Three Months Ended<br>March 31, 2026** |
| | **New Business** | **After Sales** | **Total** |
| <u>Primary geographical markets</u> |  |  |  |
| &nbsp;&nbsp;&nbsp;North America | $300676 | $36646 | $337322 |
| &nbsp;&nbsp;&nbsp;Europe and ROW | 80994 | 37229 | 118223 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Sales | $381670 | $73875 | $455545 |
| <u>Timing of revenue recognition</u> |  |  |  |
| &nbsp;&nbsp;&nbsp;Products transferred at a point in time | $167225 | $68720 | $235945 |
| &nbsp;&nbsp;&nbsp;Products and services transferred over time | 214445 | 5155 | 219600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Sales | $381670 | $73875 | $455545 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31, 2025** | **Three Months Ended<br>March 31, 2025** | **Three Months Ended<br>March 31, 2025** |
| | **New Business** | **After Sales** | **Total** |
| <u>Primary geographical markets</u> |  |  |  |
| &nbsp;&nbsp;&nbsp;North America | $130256 | $17035 | $147291 |
| &nbsp;&nbsp;&nbsp;Europe and ROW | 72652 | 29243 | 101895 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Sales | $202908 | $46278 | $249186 |
| <u>Timing of revenue recognition</u> |  |  |  |
| &nbsp;&nbsp;&nbsp;Products transferred at a point in time | $141369 | $40723 | $182092 |
| &nbsp;&nbsp;&nbsp;Products and services transferred over time | 61539 | 5555 | 67094 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Sales | $202908 | $46278 | $249186 |

---

**NOTE 3 – INVENTORIES**

Inventories are summarized as follows:

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| Finished goods | $123163 | $113716 |
| Work in process | 50643 | 49713 |
| Raw materials and purchased components | 205380 | 182994 |
| Total Inventories | $379186 | $346423 |

---

Page 11 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

**NOTE 4 – PROPERTY, PLANT AND EQUIPMENT**

Property, plant and equipment are summarized by major classifications as follows:

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| Land and Building | $136807 | $135760 |
| Technical installation and machinery | 92257 | 91843 |
| Plant and office equipment | 55745 | 55871 |
| Assets under construction | 5377 | 8474 |
| Subtotal | 290186 | 291948 |
| Less: accumulated depreciation | (127560) | (124049) |
| Total Property, plant and equipment, net | $162626 | $167899 |

---

The Company recorded depreciation expense of $5,513 and $2,845 during the three months ended March 31, 2026 and 2025, respectively.

**NOTE 5 – LEASES**

The Company has both operating and finance leases for land, buildings, machinery, vehicles and certain equipment. Our leases have remaining lease terms of 1 to 25 years, some of which include options to extend the lease agreements for up to 12 years. Our leases do not contain residual value guarantees. As of March 31, 2026, and December 31, 2025, assets recorded under finance leases were immaterial.

Operating lease expenses are classified as cost of products sold and selling, general and administrative on the Condensed Consolidated Statements of Operations. The components of lease expense were as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Operating leases | $7676 | $3452 |
| Finance leases |  |  |
| &nbsp;&nbsp;Amortization of right of use assets | 240 | 122 |
| &nbsp;&nbsp;Interest on lease liabilities | 21 | 9 |
| Short-term leases | 289 | 61 |
| Variable lease expense | 113 | 119 |
| Sublease income | (416) | (373) |
| Total lease expense | $7923 | $3390 |

---

The weighted average remaining lease term and weighted average discount rate were as follows:

---

| | | |
|:---|:---|:---|
| | **March 31,** | **March 31,** |
| | **2026** | **2025** |
| Weighted average remaining lease term (in years) |  |  |
| &nbsp;&nbsp;Finance leases | 3 | 3 |
| &nbsp;&nbsp;Operating leases | 12 | 12 |
| Weighted average discount rate |  |  |
| &nbsp;&nbsp;Finance leases | 3.91% | 2.16% |
| &nbsp;&nbsp;Operating leases | 5.95% | 5.42% |

---

Page 12 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

Supplemental cash flow information related to leases was as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Cash paid for amounts included in the measurement of lease liabilities: |  |  |
| Finance leases - Financing cash flows | $338 | $259 |
| Finance leases - Operating cash flows | 21 | 9 |
| Operating leases - Operating cash flows | 7055 | 3434 |
| Right of use assets obtained in exchange for lease obligations: |  |  |
| Operating leases | 6189 | 6207 |
| Finance leases | 45 | 213 |
|  | $6234 | $6420 |

---

Maturities of lease liabilities as of March 31, 2026, are as follows:

---

| | | |
|:---|:---|:---|
| Years ending December 31: | **Finance** | **Operating** |
| 2026 | $971 | $20718 |
| 2027 | 478 | 24215 |
| 2028 | 347 | 21265 |
| 2029 | 253 | 19677 |
| 2030 | 119 | 17912 |
| 2031 | 41 | 16450 |
| Thereafter |  | 116297 |
| Total lease payments | 2209 | 236534 |
| Less: imputed interest | $(129) | $(73377) |
| Total lease liabilities | $2080 | $163157 |

---

**NOTE 6 – INCOME TAXES**

At the end of each interim period, the Company makes its best estimate of the annual expected effective income tax rate and applies that rate to its ordinary year-to-date earnings or loss. The income tax provision or benefit related to unusual or infrequent items, if applicable, that will be separately reported or reported net of their related tax effects are individually computed and recognized in the interim period in which those items occur. In addition, the effect of changes in enacted tax laws or rates, tax status, judgment on the realizability of a beginning-of-the-year deferred tax asset in future years or income tax contingencies is recognized in the interim period in which the change occurs.

Our income tax expense was $488 and $787 for the three months ended March 31, 2026, and 2025*,* respectively. The tax expense represented a 42.1% and 27.6% effective tax rate for the three months ended March 31, 2026, and 2025, respectively.

The Organization for Economic Cooperation and Development's ("OECD") Pillar Two global corporate minimum tax rate of 15% has been in effect since 2024 and applies for companies with revenues of at least €750 million. The Company is subject to the Pillar Two regulations. The Company has continued to evaluate the effect of this through the first quarter of 2026 and determined that it did not have any material impacts for the current year. The Company will continue to assess the impact of the Pillar Two minimum tax regulations, including the impact from additional clarifications that are published by OECD and local tax authorities.

On July 4, 2025, the United States enacted the One Big Beautiful Bill Act of 2025 ("OBBBA") into law. The OBBBA includes provisions allowing accelerated tax deductions for qualified property and research expenditures and limitations on business interest deductions. The OBBBA has multiple effective dates, with certain provisions effective in 2025 and others

Page 13 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

being implemented through 2027. The enactment of the OBBBA did not have a material impact on the Company's effective tax rate for the three months ended March 31, 2026. Administrative guidance interpreting the OBBBA will be released over coming quarters which the Company will continue to monitor.

**NOTE 7 – COMMITMENTS AND CONTINGENT LIABILITIES**

*Warranty Related*

We provide limited warranties against assembly or construction defects. These warranties generally provide for the replacement or repair of defective parts or workmanship for a specified period following the date of sale. The end users also may receive limited warranties from suppliers of components that are incorporated into our chassis and vehicles.

Certain warranty and other related claims involve matters of dispute that ultimately are resolved by negotiation, arbitration or litigation. Infrequently, a material warranty issue can arise which is beyond the scope of our historical experience. We provide for any such warranty issues as they become known and are estimable. It is reasonably possible that additional warranty and other related claims could arise from disputes or other matters beyond the scope of our historical experience. An estimate of possible penalty or loss, if any, cannot be made at this time.

Changes in the warranty liability are summarized below:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Balance of warranty liability, beginning of period | $20303 | $10205 |
| Accruals for current period sales | 1481 | 1265 |
| Cash settlements | (1576) | (546) |
| Changes in liability for pre-existing warranties | (262) | (8) |
| Translation adjustment | (212) | 289 |
| Balance of warranty liability, end of period | $19734 | $11205 |

---

Long-term warranty provision amounting to $2,586 and $1,807 as of March 31, 2026 and 2025, respectively is included within the Other non-current liabilities in the Condensed Consolidated Balance Sheets.

**Chassis Pool Agreements**

As of March 31, 2026, and December 31, 2025, chassis consigned inventory was approximately $77,502 and $119,091 respectively. The Company incurred $1,351 and $309 of interest expense related to the chassis on hand during the three months ended March 31, 2026 and 2025, respectively. For additional information regarding our chassis pool agreements, refer to our audited consolidated financial statements and footnotes in the Company's Form 10-K. For further information regarding our chassis pool agreements, please refer to "*Note 8 - Commitments and Contingent Liabilities*" in the Company's Form 10-K.

**NOTE 8 – DEFINED BENEFIT PENSION PLANS**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| Service cost | $668 | $607 |
| Interest cost | 509 | 388 |
| Interest income | (1219) | (1058) |
| Amortization of net gain | (128) | (227) |
| Administrative expenses | 51 | 44 |
| Total Benefit cost | $(119) | $(246) |

---

Page 14 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

The components of net periodic pension and other postretirement cost, other than service cost, are included in Other income (expense) in our Condensed Consolidated Statements of Operations.

**NOTE 9 – DEBT**

Debt consists of the following:

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| Revolving credit facility, due 2030 | $208640 | $191819 |
| Term loan, Facility A, due 2030 | 325412 | 328377 |
| Shareholder loan | 58213 | 59101 |
| Other debt | 36604 | 15661 |
| Total debt | 628869 | 594958 |
| Less current portion of long-term debt | (67911) | (46908) |
| Total long-term debt | $560958 | $548050 |

---

**Term loan, Facility A, due 2030**

Facility A is a multicurrency senior secured amortizing term loan facility with a total commitment amount of $350,000. The interest rate is variable defined based on the applicable reference rate (SOFR, SARON, EURIBOR), plus a margin. The margin increases with the Company's leverage ratio. The average interest rate for the three months ended March 31, 2026 was 6.307%.

As of March 31, 2026, debt issuance costs of $4,532 are deferred and amortized based on the effective interest method and $267 have been written off for the three months ended March 31, 2026.

The Company is subject to certain customary covenants that prohibit the Company from incurring additional indebtedness, limit certain acquisitions, investments, advances or loans and restrict substantial asset sales (all subject to certain exceptions and baskets). In addition, the credit facilities agreement governing Facility A (the "New Credit Facilities Agreement") also requires the Company to maintain certain financial ratios. For the current reporting period, the Company was required to maintain a leverage ratio that did not exceed 3.75x. The Company was in compliance with all covenants as of March 31, 2026 and December 31, 2025.

**Revolving credit facility, due 2030**

The New Credit Facilities Agreement also provides for a multicurrency senior secured revolving loan facility (the "Revolving Facility") with a total commitment amount of up to $250,000. The interest rate is variable and based on the applicable a reference rate (SOFR, SARON, EURIBOR), plus a margin. The margin increases with the Company's leverage ratio. The average interest rate for the three months ended March 31, 2026 was 6.253%.

As of March 31, 2026, debt issuance costs of $3,237 are deferred and amortized based on a straight-line basis over the term of the debt and $190 have been written off for the three months ended March 31, 2026.

The Company is subject to certain customary covenants that prohibit the Company from incurring additional indebtedness, limit certain acquisitions, investments, advances or loans and restrict substantial asset sales (all subject to certain exceptions and baskets). In addition, the New Credit Facilities Agreement also requires the Company to maintain certain financial ratios. For the current reporting period, the Company was required to maintain a leverage ratio that did not exceed 3.75x. The Company was in compliance with all covenants as of March 31, 2026 and December 31, 2025.

**Shareholder loans**

As of March 31, 2026 and December 31, 2025, there were subordinated shareholder loans totaling CHF13,563 (2026: $16,962, 2025: $17,110) and EUR15,000 (2026: $17,247, 2025: $17,626) from PCS Holding AG, as well as CHF10,000 (2026: $12,506, 2025: $12,615) and EUR10,000 (2026: $11,498, 2025: $11,750) from Gebuka AG. The loans are originally granted for a fixed term, but the term will be extended if the loan agreement is not terminated 90 days prior to the

Page 15 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

end date or if an extension agreement is signed. The change in the loan balance as of March 31, 2026 and December 31, 2025, is solely due to foreign exchange rate fluctuations. These shareholder loans were renewed and amended in connection with entry into the New Credit Facilities Agreement.

**Other debt**

In the first quarter of 2026, the Company entered into an uncommitted revolving credit facility with a maximum availability of $20,000 and maturity date February 9, 2027. The facility bears interest at variable rates based on applicable reference rates (e.g., SOFR, SARON or EURIBOR) plus a margin. The average interest rate for the three months ended March 31, 2026 was 5.923%. The agreement includes customary terms and conditions, including representations and warranties, events of default and covenants typical for facilities of this nature. The lender may cancel the facility any time on short notice. As of March 31, 2026, there was $20,000 outstanding under the facility. This debt is included in "Other debt" in the table above.

**Off-balance sheet arrangements**

The contingent liabilities include guarantees amounting to $19,234 and $20,246 as of March 31, 2026 and December 31, 2025, respectively. Through the normal course of bidding for and executing certain projects, the Company has entered into bid/performance bonds and surety bonds (collectively "performance bonds") with various financial institutions. Customers can draw on such performance bonds if the Company does not fulfil its contractual obligations. If a performance bond is drawn, the Company would have an obligation to reimburse the financial institution for amounts paid. There have been no significant amounts reimbursed to financial institutions under these types of arrangements for the three months ended March 31, 2026 and 2025.

**NOTE 10 – ACCUMULATED OTHER COMPREHENSIVE INCOME**

The components of AOCI, net of tax are as follows:

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **March 31,<br>2025** |
| Foreign currency translation adjustments | $10408 | $9245 |
| Pension benefits | 18322 | 26391 |
| Total accumulated other comprehensive income | $28730 | $35636 |

---

**NOTE 11 – EARNINGS PER SHARE**

Basic earnings per share is computed using the weighted-average number of outstanding shares of common stock during the period. Diluted earnings per share is computed using the weighted-average number of outstanding shares of common stock and, when dilutive, potential outstanding shares of common stock during the period. Potential shares of common stock are calculated using the treasury-stock method and consist of incremental shares issuable upon the vesting of the equity classified restricted stock awards granted in June 2025, Aebi Schmidt restricted stock awards ("RSAs") and the Aebi Schmidt restricted stock units ("RSUs"). The computation of both earnings per share is as follows:

Page 16 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

---

| | | |
|:---|:---|:---|
| | **Three months ended March 31,** | **Three months ended March 31,** |
| | **2026** | **2025** |
| | (in thousands, except per share data) | (in thousands, except per share data) |
| Basic earnings per share: |  |  |
| Net income | $695 | $2075 |
| Shares used in computation: |  |  |
| Weighted-average shares of common stock outstanding | 77106 | 40352 |
| Basic earnings per share | $0.01 | $0.05 |
| Diluted earnings per share: |  |  |
| Net income | $695 | $2075 |
| Shares used in computation: |  |  |
| Weighted-average share of common stock outstanding | 77106 | 40352 |
| Effect of dilutive stock-based awards | 300 |  |
| Weighted-average number of shares | 77406 | 40352 |
| Diluted earnings per share | $0.01 | $0.05 |

---

**NOTE 12 – BUSINESS COMBINATION**

On July 1, 2025 ("Acquisition Date"), the Company acquired all outstanding equity of Shyft, a niche market leader in specialty vehicle manufacturing and assembly for the commercial and recreational vehicle industries, pursuant to the Merger Agreement. For further information regarding the Merger please refer to "*Note 1- Nature of Operations and Basis of Presentation*".

The Company acquired 100% of Shyft's voting equity interests, with the primary motivation being to enhance the Company's product offerings in specialty vehicle solutions, expand market share in North America, and leverage Shyft's innovative design and manufacturing capabilities. Shyft will expand the Company's ability to provide customized vehicle solutions, including walk-in vans, truck bodies, and luxury Class A diesel motorhome custom chassis to a diverse clientele, including commercial users, original equipment manufacturers, dealers, and governmental entities, thereby providing a diversified portfolio that mitigates risk across various market cycles. Shyft was headquartered in Novi, Michigan, and is integrated into the North America Segment. Shyft's annual sales in 2024 were $786,176.

The total consideration transferred was approximately $443,103. The assets acquired and liabilities assumed were recorded at their fair values as of the Acquisition Date. The Shyft acquisition was accounted for using the acquisition method of accounting with the purchase price allocated to the assets purchased and liabilities assumed based upon their estimated fair values at the date of acquisition. Identifiable intangible assets include Brand, Technology, Customer relationships and Order backlog. The excess of the purchase price over the estimated fair values of assets acquired and liabilities assumed was recorded as goodwill. In accordance with ASC 805-30-50-1(a), the goodwill recognized in this acquisition is attributed to several qualitative factors, including expected synergies from the integration of the operations of the acquiree and the acquirer, intangible assets that do not qualify for separate recognition, and other relevant factors. All of the goodwill has been assigned to the North America reporting unit, which is included in the North America reportable segment. Goodwill totaled $182,492 and is not deductible for tax purposes.

In accordance with ASC 805, the allocation of the purchase price for the acquisition of Shyft is preliminary and subject to adjustment during the measurement period, which may extend up to one year from the Acquisition Date. The initial allocation of assets acquired and liabilities assumed is based on preliminary estimates and assumptions, and as such, the values assigned to certain working capital balances, identifiable intangible assets, property, plant and equipment, taxes, and contingent liabilities may be adjusted as additional information becomes available. These adjustments could result in changes to the amounts recognized in the Consolidated Financial Statements, including potential adjustments to the goodwill recognized. The Company will continue to refine its estimates and assumptions as it obtains more information, and any adjustments identified during the measurement period will be recognized in the reporting period in which the adjustments are determined.

Page 17 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

The Company (i) issued and delivered to Shyft shareholders an aggregate of 36,350,634 shares of Aebi Schmidt Common Stock at $12.06 per share, (ii) paid to Shyft fractional shareholders an aggregate amount in cash equal to $2 (the "Cash Consideration") and (iii) replaced Shyft equity awards amounting to $4,866 that are allocated to consideration transferred as they relate to the pre-acquisition period. The $443,103 of common stock was entirely comprised of Aebi Schmidt Common Stock, par value $1.00.

The purchase price was comprised of the following:

---

| | |
|:---|:---|
| Purchase price: |  |
| Aebi shares issued to Shyft shareholders on July 1, 2025 <sup>(1)</sup> | 36350634 |
| Shyft stock price on June 30, 2025 <sup>(2)</sup> | $12.54 |
| Exchange ratio | 1.04 |
| Share consideration (36,350,634 number of shares issued at the Fair Value of $12.06 per share) | $438235 |
| Add: Cash paid for fractional shares | 2 |
| Add: Fair value of Shyft Equity awards allocated to pre-acquisition period <sup>(3)</sup> | 4866 |
| Total purchase price | $443103 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup>Includes vested Shyft Director RSU awards.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(2)</sup>The fair value of the share consideration and the replacement awards issued to Shyft employees was determined using Shyft's stock price, as it was considered more reliably measurable than the stock price of Aebi Schmidt. The measurement was based on Shyft's stock price as of June 30, 2025, the last trading day prior to delisting, which occurred on the Acquisition Date of July 1, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(3)</sup>Represents the estimated fair value of Shyft RSAs, Shyft RSUs (other than Shyft Director RSUs), and Shyft performance stock units ("PSUs") attributable to pre-combination services. $501 of Shyft RSAs, $1,585 of Shyft RSUs, and $2,780 of Shyft PSUs are attributed to pre-combination service.

The total number of shares of Aebi Schmidt Common Stock issued as consideration, after adjusting for unvested RSAs, vested Director RSUs, and excluding fractional shares settled in cash, was 36,696,981 shares. This total comprises 36,350,634 shares issued to Shyft shareholders, of which 105,874 relating to Aebi Schmidt RSAs exchanged for Shyft RSAs that have not fully vested, and 346,347 shares that accelerated vesting upon a termination and change in control (double trigger provision). For further information regarding stock based compensation, please refer to "*Note 13 - Stock Based Compensation and Equity*" in the Company's Form 10-K.

Acquisition costs in connection with the Merger incurred by the Company include acquisition-related legal and other professional fees in the total amount of $19,169 as of the Acquisition Date, which are recognized as $14,765 and $4,404 in the income statement for the year ended December 31, 2025 and 2024, respectively. All amounts were recorded within other income (expense) for the respective periods.

The table below presents the preliminary purchase price allocation to the estimated fair value of identifiable assets acquired and liabilities assumed as of the Acquisition Date. Measurement period adjustments were based upon information obtained about facts and circumstances that existed at the acquisition date that, if known, would have affected the measurement of the amounts recognized at that date. In the fourth quarter of 2025, the Company recorded measurement period adjustments to cash and cash equivalents, other current liabilities and accrued expenses, and intangible assets. We also adjusted deferred tax liabilities in the fourth quarter of 2025 to reflect measurement-period refinements to our estimated deferred tax calculation. In the first quarter of 2026, the Company recorded measurement period adjustments to other current liabilities and accrued expenses. The offset to these adjustments were recorded as a net decrease to goodwill.

The purchase price allocation to the fair value of assets acquired and liabilities assumed is as follows:

---

| | | | |
|:---|:---|:---|:---|
| | Purchase Price Allocation | Measurement Period Adjustments | Purchase Price Allocation (As Adjusted) |
| Fair value of identifiable assets and liabilities: |  |  |  |
| Cash and cash equivalents | $19905 | $(539) | $19366 |

---

Page 18 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

---

| | | | |
|:---|:---|:---|:---|
| Accounts receivable | 84121 |  | 84121 |
| Contract assets | 44559 |  | 44559 |
| Inventories | 91117 |  | 91117 |
| Prepaid expenses and other current assets | 8191 |  | 8191 |
| **Total current assets** | **247893** | **(539)** | **247354** |
| Property, plant and equipment | 101832 |  | 101832 |
| Goodwill | 193960 | (11468) | 182492 |
| Intangible assets | 181104 | 1682 | 182786 |
| Right of use assets operating leases | 47347 |  | 47347 |
| Other assets | 1317 |  | 1317 |
| **Total Assets** | $773453 | $(10325) | $763128 |
| Accounts payable | $80844 |  | $80844 |
| Accrued warranty | 6782 |  | 6782 |
| Accrued compensation and related taxes | 11174 |  | 11174 |
| Contract liabilities | 9123 |  | 9123 |
| Operating lease liability | 9221 |  | 9221 |
| Other current liabilities and accrued expenses | 25574 | 4223 | 29797 |
| Current portion of long-term debt | 452 |  | 452 |
| **Current liabilities** | $**143170** | $**4223** | $**147393** |
| Other non-current liabilities | 12205 |  | 12205 |
| Long-term operating lease liability | 34346 |  | 34346 |
| Long-term debt, less current portion | 120344 |  | 120344 |
| Deferred tax liabilities | 20285 | (14548) | 5737 |
| Total liabilities | 330350 | (10325) | 320025 |
| **Total fair value allocation of purchase price** | $**443103** | $**—** | $**443103** |

---

The value of accounts receivables acquired approximates the gross contractual amount of accounts receivable. The contractual amount not expected to be collected is immaterial.

As part of the business combination, the Company recognized contingent liabilities of $8,246 related to certain commitments. The Company measured these contingencies at fair value and the liabilities reflect management's best estimate of future payments related to these arrangements, which depends on final negotiated terms following the acquisition. The valuation incorporates probability-weighted scenarios based on expected outcomes. The Company continues to monitor these arrangements and will adjust the fair value as necessary in future reporting periods.

Intangible assets totaling $182,786 have provisionally been assigned to Brand, Technology, Customer relationships and Order backlog as a result of the acquisition. The fair value of Customer relationships was determined using an income approach methodology, specifically the multi-period excess earnings method. The fair value of Brand and Technology was determined using an income approach methodology, specifically the relief from royalty method. Significant assumptions used in estimating future cash flows included projected revenue growth rates and discount rate for customer relationships and projected revenue growth rates, royalty rate and discount rate for brand. Intangible assets consist of the following (in thousands):

---

| | | | |
|:---|:---|:---|:---|
| | **Amount** | **Useful life (in years)** | **Weighted average amortization period (in years)** |
| Brand | $60858 | 5 - 20 | 18 |
| Technology | 26097 | 10 | 10 |
| Customer relationships | 90882 | 15 | 15 |

---

Page 19 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

---

| | | |
|:---|:---|:---|
| Order backlog | 4949 | 1 |
|  | $182786 | 15 |

---

The Company amortizes the Brand, Technology, Customer relationships and Order backlog utilizing a straight-line approach.

For the three months ended March 31, 2026, Shyft generated revenue of $186,304 and operating income of $1,652, which are included in the accompanying condensed consolidated financial statements.

The Company has applied the practical expedient in ASC 805-20-30-29 for contract assets and contract liabilities acquired in the business combination. Acquired contract assets and liabilities in the scope of ASC 606 are an exception to the ASC 805 fair value measurement principle and were measured as if Aebi Schmidt had originated the acquired contract. For each contract Aebi Schmidt reassessed the identification of performance obligations, determination of transaction price, allocation of transaction price, and measure of progress for each performance obligation as if Aebi Schmidt has been party to the original contract and recognized the resulting contract asset or liability as an asset acquired or a liability assumed. The application of this expedient aligns with the acquiree's historical accounting and is not expected to materially affect the condensed consolidated financial statements. The Company continues to evaluate the impact of these items in subsequent periods as part of its ongoing revenue recognition processes.

Supplemental Pro Forma (unaudited)

The following table summarizes the unaudited supplemental pro forma financial information for the three-month period ended March 31, 2025, as if the acquisition was completed on January 1, 2025. The unaudited pro forma information was prepared in accordance with the requirements of ASC 805. Pro forma adjustments have been made to reflect the impact of incremental non-recurring acquisition-related adjustments, including transaction costs of $10,122, cash retention awards of $2,022, share-based compensation of $1,390, employee severance of $15,140 and adjustment related to fair value step-up to inventory of $936. The adjustments also include the interest expense related to the debt modification, amortization of acquired intangible assets and lease remeasurement, depreciation of the fair-valued tangible assets, and the related tax effects of these adjustments.

---

| | |
|:---|:---|
| (In thousands amounts) | **Three Months Ended March 31, 2025** |
| Revenue | $452522 |
| Net loss | $(27595) |

---

The unaudited supplemental pro forma financial information is presented for illustration purposes only and is not necessarily indicative of the operating results that would have occurred had the transaction been completed on January 1, 2025, nor is it necessarily indicative of future operating results of the combined entity. The unaudited pro forma financial information for the three-month period ended March 31, 2025, is a result of combining the consolidated income statement of the Company with the results of the net assets acquired from Shyft. The pro forma results do not include any cost savings and synergies anticipated as a result of the transaction. We believe the estimates and assumptions are reasonable, and the relative effects of the transaction are properly reflected.

**NOTE 13 – SEGMENTS**

The Company identifies its operating and reportable segments based on the management structure and the financial data utilized by the chief operating decision maker ("CODM"), which was determined to be the Board of Directors, to assess segment performance and allocate resources among the operating units.

The Company's segment reporting policy identifies two operating segments, North America, and Europe and the Rest of the World, ("ROW"), as reportable segments. Financial results for each segment are presented separately to provide transparency and insight into the performance and resources of each geographic area, consistent with how the CODM reviews and assesses the Company's operations.

The CODM evaluates the performance of their reportable segments based on Segment Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization), which is defined as net income before interest, taxes, depreciation, and

Page 20 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

amortization, further adjusted for foreign exchange gains and losses on external debt, restructuring and other related expenses, transaction related expenses, bargain purchase gains on acquisitions, changes in repurchase liabilities for Aebi Schmidt's employee share plan, non-service cost related pension expenses, legacy legal matters, sales executive transition costs, changes in provisions for contingencies, and other non-recurring items.

Interest expense and taxes on income are not included in the information utilized by the CODM to assess segment performance and allocate resources, and accordingly, are excluded from the segment results presented below.

The Company's Board of Directors assesses the Segment Adjusted EBITDA to compare to historical trends and the forecast to assess segment results, allocate capital, make strategic decisions and identify areas of opportunity.

Sales and other financial information by reportable segment for the three months ended March 31, 2026, and March 31, 2025, are as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31, 2026** | **Three Months Ended<br>March 31, 2026** | **Three Months Ended<br>March 31, 2026** |
| | **Segment** | **Segment** | **Segment** |
| | **North America** | **Europe and <br>ROW** | **Total** |
| New Business | $300676 | $80994 | $381670 |
| After Sales | 36646 | 37229 | 73875 |
| Segment sales | $337322 | $118223 | $455545 |
| Depreciation and amortization expense | $12215 | $1588 | $13803 |
| Segment assets | $1498765 | $508350 | $2007115 |
| Capital expenditures | $867 | $1099 | $1966 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31, 2025** | **Three Months Ended<br>March 31, 2025** | **Three Months Ended<br>March 31, 2025** |
| | **Segment** | **Segment** | **Segment** |
| | **North America** | **Europe and <br>ROW** | **Total** |
| New Business | $130256 | $72652 | $202908 |
| After Sales | 17035 | 29243 | 46278 |
| Segment sales | $147291 | $101895 | $249186 |
| Depreciation and amortization expense | $5139 | $1486 | $6625 |
| Segment assets | $696745 | $420346 | $1117091 |
| Capital expenditures | $2157 | $963 | $3120 |

---

Page 21 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

Segment Adjusted EBITDA is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31, 2026** | **Three Months Ended<br>March 31, 2026** | **Three Months Ended<br>March 31, 2025** | **Three Months Ended<br>March 31, 2025** |
| | **North <br>America** | **Europe and <br>ROW** | **North America** | **Europe and <br>ROW** |
| Sales | $337322 | $118223 | $147291 | $101895 |
| Cost of products sold | 276035 | 92121 | 116909 | 78971 |
| Research and development | 1633 | 5068 | 601 | 4026 |
| Selling, general and administrative | 39322 | 19225 | 12534 | 18190 |
| Other segment items<sup>(1)</sup> | (6031) | (4945) | (1789) | (1533) |
| Segment Adjusted EBITDA | $26363 | $6754 | $19036 | $2241 |

---

<sup>(1)</sup> Other segment items include, other operating income and expenses, other income and expenses, depreciation and amortization, transaction related expenses, non-service cost related pension expense and legacy plan, foreign exchange gain on external debts and other non-recurring.

The reconciliation of total Segment Adjusted EBITDA to Income before income taxes as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Total Segment Adjusted EBITDA | $33117 | $21277 |
| Interest expense | (11350) | (6503) |
| Foreign exchange losses on external debt | (300) | (982) |
| Depreciation and amortization | (13803) | (6625) |
| Restructuring and other related expenses | (915) | (374) |
| Transaction related expenses |  | (4643) |
| Integration costs | (3301) |  |
| Settlement of acquisition | (434) | (412) |
| Pension related income, net | 776 | 929 |
| Legal matters | (1427) |  |
| Change in provision for contingencies | 288 | 210 |
| Non-cash stock-based compensation expenses | (535) |  |
| Other non-operating one-off items | (957) | (28) |
| Income before income taxes | $1159 | $2849 |

---

Page 22 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

The following table presents sales disaggregated by geography which exceed 10% of total sales:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| U.S. | $328238 | $134448 |
| Switzerland | 13290 | 11205 |
| Other | 114017 | 103533 |
| Total sales | $455545 | $249186 |
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
|  | **2026** | **2025** |
| U.S. | 72.1% | 54.0% |
| Switzerland | 2.9% | 4.5% |
| Other | 25.0% | 41.5% |
| Total sales | 100.0% | 100.0% |

---

The following table presents assets disaggregated by geography that exceeds 10% of total assets:

---

| | | |
|:---|:---|:---|
| | **As of** | **As of** |
| | **March 31, 2026** | **December 31, 2025** |
| U.S. | $1471399 | $1495145 |
| Switzerland | 210818 | 177549 |
| Other | 324898 | 335585 |
| Total assets | $2007115 | $2008279 |
|  | **As of** | **As of** |
|  | **March 31, 2026** | **December 31, 2025** |
| U.S. | 73.3% | 74.4% |
| Switzerland | 10.5% | 8.8% |
| Other | 16.2% | 16.8% |
| Total assets | 100.0% | 100.0% |

---

Page 23 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

**Item 2.&nbsp;&nbsp;&nbsp;&nbsp;MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION** 

**AND RESULTS OF OPERATIONS** 

**Forward-Looking Statements**

The following discussion and analysis of the financial condition and results of operations of Aebi Schmidt should be read together with Aebi Schmidt's unaudited condensed consolidated financial statements, and the related notes thereto, included elsewhere in this Quarterly Report. Unless the context requires otherwise, references to "Aebi Schmidt" in this section of the Quarterly Report refer to Aebi Schmidt and its consolidated subsidiaries. The information presented herein is based on management's perspective of Aebi Schmidt's results of operations. The following discussion contains forward-looking statements that reflect future plans, estimates, beliefs and expected performance. The forward-looking statements are dependent upon events, risks and uncertainties that may be outside of Aebi Schmidt's control. Aebi Schmidt's actual results may differ significantly from those projected in the forward-looking statements. Factors that might cause future results to differ materially from those projected in the forward-looking statements include, but are not limited to, those discussed in the section following the cover page to this Quarterly Report entitled "*Forward-Looking Statements*", and Part II, Item 1A of this Quarterly Report (*Risk Factors*), as well as the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 (the "Form 10-K").

**Overview**

Aebi Schmidt is a provider of innovative technical products for cleaning and clearing traffic areas as well as mowing green spaces in particularly challenging terrain. The range of products include vehicles, attachable and demountable devices for individual vehicle equipment as well as related services. In addition, the Company manufactures and assembles specialty vehicles for commercial and recreational applications, including walk-in vans, truck bodies for last-mile delivery, vocation-specific upfit solutions, and luxury motorhome chassis. It also offers replacement parts, repair, maintenance, and refurbishment services for these vehicles. Aebi Schmidt covers the European and North American markets with its own sales organizations while clients outside of these markets are served either directly by the exporting subsidiary or indirectly by the worldwide dealer network.

On July 1, 2025, Aebi Schmidt acquired 100% of the outstanding equity interests of The Shyft Group, Inc. ("Shyft"), a niche market leader in specialty vehicle manufacturing and assembly for the commercial and recreational vehicle industries, through a merger (the "Merger"). The Merger involved 100% of the voting equity interests of Shyft, with the primary reasons for the combination being to enhance our product offerings in specialty vehicle solutions, develop our market share in North America, and to leverage Shyft's innovative design and manufacturing capabilities.

Aebi Schmidt operates in two reportable segments, which consist of (i) North America and (ii) Europe and the Rest of the World ("ROW"). Operating results for the three months ended March 31, 2026 are not necessarily indicative of the results we may achieve for the full year ending December 31, 2026.

***North America***

Aebi Schmidt North America segment offers a wide range of vehicles, equipment, and services primarily across four of our five lines of business: Airport & Chassis, Commercial Trucks, Goods Transport, and Municipal. Aebi Schmidt operates as a key player in providing innovative solutions for snow removal, street cleaning, and other essential services that enhance infrastructure and public safety. The Merger with Shyft in July 2025 allowed Aebi Schmidt to penetrate additional markets and product lines, as well as combine Aebi Schmidt's commercial business with Shyft's fleet and commercial business, optimizing Aebi Schmidt's purchasing and production capacity.

***Europe and the ROW***

In Europe and the ROW, Aebi Schmidt offers a wide range of vehicles, equipment and services primarily across three of our five lines of business: Airport & Chassis, Municipal and Agriculture. Aebi Schmidt has long-lasting relationships with airports and municipalities across Europe and with international customers. Aebi Schmidt offers a wide range of products tailored to European and international markets, including snowplows, street sweepers, multifunctional vehicles, and specialized equipment for airport operations. Aebi Schmidt has established a strong reputation for quality and reliability, with innovative solutions that enhance efficiency and sustainability through its technological features.

**Key Performance Indicators**

Aebi Schmidt reviews the following key performance indicators on a regular basis in order to evaluate the financial and operating performance of its business, identify trends affecting its performance, prepare financial projections, and make strategic decisions. Aebi Schmidt's key performance indicators are not based on any standardized industry

Page 24 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

methodology and are not necessarily calculated in the same manner or comparable to similarly titled measures presented by other companies. Similarly, Aebi Schmidt's key metrics may differ from estimates published by third parties or from similarly titled metrics of its competitors due to differences in methodology. The numbers that Aebi Schmidt uses to calculate its key performance indicators are based on internal data. While these numbers are based on what Aebi Schmidt believes to be reasonable judgments and estimates for the applicable period of measurement, there are inherent challenges in measuring usage and engagement. Increases or decreases in Aebi Schmidt's key performance indicators may not correspond with increases or decreases in its revenue. Aebi Schmidt regularly reviews and may adjust its processes for calculating its internal metrics to improve their accuracy. In addition to the key performance indicators summarized below, Aebi Schmidt also evaluates certain non-GAAP financial measures (i.e., Adjusted EBITDA and Adjusted EBITDA margin), which are further summarized in the Non-GAAP Financial Measures section below.

The following table presents a summary of Aebi Schmidt's key performance indicators for the three months ended March 31, 2026 and March 31, 2025.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| *(in thousands, except percentages)* | **2026** | **2025** |
| Sales | $455545 | $249186 |
| Net income | 671 | 2062 |
| Net income margin | 0.15% | 0.8% |
| Adjusted EBITDA<sup>(1)</sup> | 33117 | 21277 |
| Adjusted EBITDA margin<sup>(1)</sup> | 7.27% | 8.5% |
| Net cash used in operating activities | (17739) | (26561) |

---

(1)Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP financial measures. See the section titled "Non-GAAP Financial Measures" below for the definitions of these measures and the reconciliations to the most directly comparable U.S. GAAP financial measure.

**Results of Operations**

***Three months ended March 31, 2026 compared with three months ended March 31, 2025***

Page 25 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

Results for Aebi Schmidt for the three months ended March 31, 2026, compared to results for the three months ended March 31, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months Ended March 31,** | **For the Three Months Ended March 31,** | **For the Three Months Ended March 31,** | **For the Three Months Ended March 31,** |
| *(in thousands, except percentages)* | **2026** | **2025** | **$ Change** | **% Change** |
| Sales | $455545 | $249186 | $206359 | 83% |
| Cost of products sold | (368156) | (195880) | (172276) | 88% |
| **Gross profit** | 87389 | 53306 | **34083** | **64%** |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;Research and development | (6701) | (4627) | (2074) | 45% |
| &nbsp;&nbsp;Selling, general and administrative | (58547) | (30724) | (27823) | 91% |
| &nbsp;&nbsp;Amortization of purchased intangibles | (8052) | (3574) | (4478) | 125% |
| &nbsp;&nbsp;Other operating income | 1279 | 13 | 1266 | n.m. |
| Total operating expenses | (72021) | (38912) | (33109) | 85% |
| **Operating income** | **15368** | **14394** | **974** | **7%** |
| Other income (expense): |  |  |  |  |
| &nbsp;&nbsp;Interest expense | (11350) | (6503) | (4847) | 75% |
| &nbsp;&nbsp;Other income (expense) | (2859) | (5042) | 2183 | (43)% |
| Total other income (expense) | (14209) | (11545) | (2664) | 23% |
| Income before income taxes | 1159 | 2849 | (1690) | (59)% |
| Income tax (expense) benefit | (488) | (787) | 299 | (38)% |
| Net income | 671 | 2062 | (1391) | (67)% |
| Less: Net income (loss) attributable to non-controlling interest | (24) | (13) | (11) | 85% |
| **Net income attributable to Aebi Schmidt Holding AG** | $**695** | $**2075** | $**(1380)** | **(67)%** |
| *n.m. – not meaningful* | *n.m. – not meaningful* | *n.m. – not meaningful* | *n.m. – not meaningful* | *n.m. – not meaningful* |

---

*Sales*

Sales increased by $206.3 million, or 83%, to $455.5 million in the three months ended March 31, 2026, from $249.2 million in the three months ended March 31, 2025. The increase in sales was primarily driven by sales attributed to Shyft of $186.3 million, an increase in new business sales of $10.1 million, and an increase in after sales of $9.9 million.

*Cost of products sold*

Cost of products sold increased by $172.3 million, or 88%, to $368.2 million in the three months ended March 31, 2026, from $195.9 million in the three months ended March 31, 2025. The increase in cost of products sold was primarily driven by $156.8 million in costs attributable to Shyft, an increase of $9.7 million in costs related to new business sales, and an increase of $5.7 million in costs related to after sales.

*Research and development expense*

Research and development expense increased by $2.1 million, or 45%, to $6.7 million in the three months ended March 31, 2026, from $4.6 million in the three months ended March 31, 2025 primarily driven by an increase of $1.0 million in activity attributable to Shyft and the development of product solutions.

*Selling, general and administrative expense*

Selling, general and administrative expense increased by $27.8 million, or 91%, to $58.5 million in the three months ended March 31, 2026, from $30.7 million in the three months ended March 31, 2025. The increase in selling, general and administrative expense was primarily driven by an increase of $22.3 million in costs attributable to Shyft, an increase in sales department costs of $2.2 million, an increase in finance department costs of $1.6 million, and an increase in IT costs of $1.3 million.

Page 26 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

*Amortization of purchased intangibles*

Amortization of purchased intangibles increased by $4.5 million, or 125%, to $8.1 million in the three months ended March 31, 2026, from $3.6 million in the three months ended March 31, 2025. The increase is primarily attributable to amortization of $4.5 million related to the intangible assets acquired as part of the Merger with Shyft.

*Other operating (income) expense*

Other operating income increased by $1.3 million to $1.3 million in the three months ended March 31, 2026, from other operating income of $0.0 million in the three months ended March 31, 2025. The increase in other operating income was primarily driven by an increase of net foreign exchange gains of $1.0 million and an increase in other income net of other expense of $0.3 million.

*Interest expense*

Interest expense increased by $4.9 million, or 75%, to $11.4 million in the three months ended March 31, 2026, from $6.5 million in the three months ended March 31, 2025. The increase in interest expense was primarily driven by an increase in interest expense attributable to Aebi Schmidt of $3.6 million, the incurrence of $0.5 million in costs related to the debt refinancing in connection with the Merger, and an increase in interest expense attributable to Shyft of $0.8 million.

*Other income (expense)*

Other expense decreased by $2.1 million to $2.9 million in the three months ended March 31, 2026, from other expense of $5.0 million in the three months ended March 31, 2025. The decrease in other expense was primarily driven by a decrease in transaction related expense of $4.6 million and decreases in net foreign exchange losses on financial positions of $0.7 million, partially offset by the incurrence of integration costs of $2.0 million and costs of legal proceedings and settlements of $1.4 million.

*Income tax (expense) benefit*

Income tax expense decreased by $0.3 million, or 38%, to $0.5 million in the three months ended March 31, 2026, from income tax expense of $0.8 million in the three months ended March 31, 2025. The decrease in income tax expense was primarily driven by lower taxable income in the three months ended March 31, 2026.

**Segment Results of Operations**

Aebi Schmidt operates its business as two reportable segments: (i) North America and (ii) Europe and ROW. Both segments operate separately with limited cross-selling activities. The information below includes Sales and Adjusted EBITDA by reportable segment, consistent with information presented for financial reporting purposes in Note 13 to Aebi Schmidt's unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.

***Three Months Ended March 31, 2026 compared with three months ended March 31, 2025***

---

| | | | |
|:---|:---|:---|:---|
| | **For the Three Months Ended March 31, 2026** | **For the Three Months Ended March 31, 2026** | **For the Three Months Ended March 31, 2026** |
| *(in thousands)* | **North<br>America** | **Europe and the<br>Rest of the World** | **Total** |
| Segment sales | $337322 | $118223 | $455545 |
| Segment Adjusted EBITDA | $26363 | $6754 | $33117 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **For the Three Months Ended March 31, 2025** | **For the Three Months Ended March 31, 2025** | **For the Three Months Ended March 31, 2025** |
| | **North<br>America** | **Europe and the<br>Rest of the World** | **Total** |
| Segment sales | $147291 | $101895 | $249186 |
| Segment Adjusted EBITDA | $19036 | $2241 | $21277 |

---

*North America*

Sales for Aebi Schmidt's North America segment increased by $190.0 million, or 129.0%, to $337.3 million in the three months ended March 31, 2026, from $147.3 million in the three months ended March 31, 2025. The increase in sales

Page 27 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

was primarily driven by sales attributable to Shyft of $186.3 million, an increase in sales of new products of $1.8 million, and an increase in after sales of $1.9 million.

Adjusted EBITDA for Aebi Schmidt's North America segment increased by $7.3 million, or 38.5%, to $26.4 million for the three months ended March 31, 2026, from $19.0 million for the three months ended March 31, 2025. The increase in Adjusted EBITDA was primarily driven by the addition of $10.6 million in activity attributable to Shyft, along with an increase in segment gross margin of $1.4 million, partially offset by an increase in selling, general and administrative expenses of $4.5 million, and a decrease in other segment items of $0.2 million.

*Europe and ROW*

Sales for Aebi Schmidt's Europe and ROW segment increased by $16.3 million, or 16.0%, to $118.2 million in the three months ended March 31, 2026, from $101.9 million in the three months ended March 31, 2025. The increase in sales was driven by an increase in sales of new products of $8.3 million and an increase in after sales of $8.0 million.

Adjusted EBITDA for Aebi Schmidt's Europe and ROW segment increased by $4.5 million, or 201.4%, to $6.8 million in the three months ended March 31, 2026, from $2.2 million in the three months ended March 31, 2025. The increase in Adjusted EBITDA was driven by an increase in segment gross margin of $3.2 million and an increase in other segment items of $3.4 million, partially offset by an increase in research and development expense of $1.0 million and an increase in selling, general and administrative expenses of $1.0 million.

**Non-GAAP Financial Measures**

Aebi Schmidt utilizes non-GAAP financial measures, Adjusted EBITDA and Adjusted EBITDA margin, to complement its U.S. GAAP reporting and to assist stakeholders in evaluating and comparing its financial and operational performance over multiple periods, identifying trends affecting its business, formulating business plans, and making strategic decisions. There can be no assurance that Aebi Schmidt will not modify the presentation of its non-GAAP financial measures in the future, and any such modification may be material.

Aebi Schmidt defines Adjusted EBITDA as net income before interest, taxes, depreciation, and amortization, further adjusted for foreign exchange gains and losses on external debt, restructuring and other related expenses, transaction related expenses, integration costs, bargain purchase gains on acquisitions, changes in repurchase liabilities for Aebi Schmidt's employee share plan, non-service cost related pension expenses, legacy legal matters, sales executive transition costs, changes in provisions for contingencies, and other non-recurring items. Aebi Schmidt defines Adjusted EBITDA margin as a ratio of Adjusted EBITDA as a percentage of sales. Management uses Adjusted EBITDA to assess Aebi Schmidt's financial performance because it allows management and stakeholders to compare its operating performance on a consistent basis across periods by removing the effects of its capital structure (such as varying levels of interest expense and income), asset base (such as depreciation and amortization) and other items (such as non-recurring costs) that impact the comparability of financial results from period to period.

In evaluating Adjusted EBITDA, you should be aware that in the future Aebi Schmidt may incur expenses that are the same as or similar to some of the adjustments in such presentation. Aebi Schmidt's presentation of Adjusted EBITDA and Adjusted EBITDA margin should not be construed as an inference that future results will be unaffected by unusual or non-recurring items. Adjusted EBITDA and Adjusted EBITDA margin have important limitations as an analytical tool, and you should not consider these measures in isolation or as a substitute for analysis of Aebi Schmidt's operating results as reported under U.S. GAAP. Adjusted EBITDA and Adjusted EBITDA margin may be defined differently by other companies in its industry and may not be comparable to similarly titled measures of other companies, thereby diminishing their utility.

Page 28 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

---

| | | |
|:---|:---|:---|
| | **For the Three Months Ended March 31,** | **For the Three Months Ended March 31,** |
| *(in thousands, except percentages)* | **2026** | **2025** |
| **Net income** | $**671** | $**2062** |
| Adjusted for: |  |  |
| Income tax (benefit) expense | 488 | 787 |
| Interest expense | 11350 | 6503 |
| Foreign exchange (gain) / losses on external debt | 300 | 982 |
| Depreciation and amortization | 13803 | 6625 |
| Restructuring and other related expenses | 915 | 374 |
| Transaction related expenses |  | 4643 |
| Integration costs | 3301 |  |
| Settlement of acquisition | 434 | 412 |
| Pension related income, net | (776) | (929) |
| Legal matters | 1427 |  |
| Change in provision for contingencies | (288) | (210) |
| Non-cash stock-based compensation expense | 535 |  |
| Other non-operating one-off items | 957 | 28 |
| **Adjusted EBITDA** | $**33117** | $**21277** |
| Sales | $455545 | $249186 |
| **Net Income Margin** | **0.15%** | **0.8%** |
| **Adjusted EBITDA Margin** | **7.27%** | **8.5%** |

---

**Liquidity and Capital Resources**

Aebi Schmidt's primary liquidity needs are to fund general business requirements, including working capital, capital expenditures, restructuring costs and debt service requirements. Aebi Schmidt's principal sources of liquidity are cash flows from operating activities, its revolving credit facility (the "Revolving Credit Facility") and other debt issuances, and existing cash balances of $115.9 million as of March 31, 2026. Aebi Schmidt actively manages its working capital and associated cash requirements and continually seeks more effective uses of cash.

As of March 31, 2026, Aebi Schmidt had $441.9 million of net working capital (i.e., current assets minus current liabilities) compared to $416.5 million of net working capital as of December 31, 2025.

Aebi Schmidt believes that its available liquidity will be sufficient to meet its current obligations for a period of at least 12 months from the date of the filing of this Quarterly Report and the foreseeable future thereafter, and its liquidity will be sufficient to finance its operating and capital needs, including day to day operations, capital expenditures, research and development, investments in information technology systems, dividends and potential future acquisitions.

Page 29 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

**Cash Flows**

Aebi Schmidt's cash flows from operating, investing and financing activities, as reflected in the Aebi Schmidt Condensed Consolidated Statements of Cash Flows are summarized in the following table:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Three Months Ended March 31,** | **For the Three Months Ended March 31,** | **For the Three Months Ended March 31,** | **For the Three Months Ended March 31,** |
| *(in thousands)* | **2026** | **2025** | **$ Change** | **%<br>Change** |
| Net cash used in operating activities | (17739) | (26561) | $8822 | (33%) |
| Net cash used in investing activities | (1055) | (3108) | 2053 | (66%) |
| Net cash provided by financing activities | 36830 | 11442 | 25388 | 222% |
| Effect of exchange rate changes on cash and cash equivalents | (662) | 872 | (1534) | (176%) |
| Net increase (decrease) in cash and cash equivalents | 17374 | (17355) | 34729 | (200%) |
| Cash and cash equivalents at beginning of the period | 98512 | 65173 | 33339 | 51% |
| **Cash and cash equivalents at end of the period** | $**115886** | $**47818** | $**68068** | **142%** |

---

<u>Net cash used in operating activities</u>

Net cash used in operating activities decreased by $8.8 million, or 33%, to $17.7 million in the three months ended March 31, 2026, from cash used in operating activities of $26.6 million in the three months ended March 31, 2025. The decrease in net cash used in operating activities was primarily driven by a decrease in net income of $1.4 million, an increase of $12.4 million in inventory levels, a decrease in accounts payable of $29.6 million due to efficient liquidity management while increasing purchases of raw materials, a decrease in income tax payable and receivable of $1.6 million and a decrease in accrued compensation and related taxes of $3.2 million. These decreases were primarily offset by an increase in collection of accounts receivable and contract assets of $34.7 million, an increase in depreciation and amortization expense of $7.2 million, an increase in other assets and liabilities of $7.7 million, an increase in contract liabilities of $5.9 million, and an increase in deferred taxes of $0.9 million.

<u>Net cash used in investing activities</u>

Net cash used in investing activities decreased by $2.0 million, or 66%, to $1.1 million in the three months ended March 31, 2026, from cash used in investing activities of $3.1 million in the three months ended March 31, 2025. The decrease was primarily driven by a decrease in cash spent on purchases of property, plant and equipment of $1.2 million and an increase on proceeds from sale of property, plant and equipment of $0.9 million.

<u>Net cash provided by financing activities</u>

Net cash provided by financing activities increased by $25.4 million, or 222%, to $36.8 million in the three months ended March 31, 2026, from $11.4 million in the three months ended March 31, 2025. The increase was primarily driven by an increase of proceeds, net of payments, of $23.9 million from long-term debt and a decrease in deferred payments made related to historical transactions of $4.8 million. The increase was partially offset by an increase in dividend payments of $2.0 million and the exercise and vesting of stock incentive awards of $1.2 million.

Page 30 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

*Debt*

---

| | | |
|:---|:---|:---|
| *In thousands* | **March 31, 2026** | **December 31, 2025** |
| Revolving credit facility, due 2030 | $208640 | $191819 |
| Term loan, Facility A, due 2030 | 325412 | 328377 |
| Shareholder loan | 58213 | 59101 |
| Other debt | 36604 | 15661 |
| Total debt | 628869 | 594958 |
| Less current portion of long-term debt | (67911) | (46908) |
| Total long-term debt | $560958 | $548050 |

---

**Term loan, Facility A, due 2030**

Facility A is a multicurrency senior secured amortizing term loan facility with a total commitment amount of $350.0 million. The interest rate is variable defined based on the applicable reference rate (SOFR, SARON, EURIBOR), plus a margin determined by the Company's leverage ratio. The average interest rate for the three months ended March 31, 2026 was 6.307%.

As of March 31, 2026, debt issuance costs of $4.5 million are deferred and amortized based on the effective interest method and $0.3 million have been written off for the three months ended March 31, 2026 due to the debt modification accounting.

The Company is subject to certain customary covenants that prohibit the Company from incurring additional indebtedness, limit certain acquisitions, investments, advances or loans and restrict substantial asset sales (all subject to certain exceptions and baskets). In addition, credit facilities agreement governing Facility A (the "New Credit Facilities Agreement") also requires the Company to maintain certain financial ratios. For the current reporting period, the Company was required to maintain a leverage ratio that did not exceed 3.75x. The Company was in compliance with all covenants as of March 31, 2026 and December 31, 2025.

**Revolving Credit Facility, due 2030**

The New Credit Facilities Agreement also provides for the Revolving Facility, which is a multicurrency senior secured revolving loan facility with a total commitment amount of up to $250.0 million. The interest rate is variable and based on the applicable a reference rate (SOFR, SARON, EURIBOR), plus a margin determined by the Company's leverage ratio. The average interest rate for the three months ended March 31, 2026 was 6.253%.

As of March 31, 2026, debt issuance costs of $3.2 million are deferred and amortized based on a straight-line basis over the term of the debt and $0.2 million have been written off for the three months ended March 31, 2026 due to the debt modification accounting.

The Company is subject to certain customary covenants that prohibit the Company from incurring additional indebtedness, limit certain acquisitions, investments, advances or loans and restrict substantial asset sales (all subject to certain exceptions and baskets). In addition, the New Credit Facilities Agreement also requires the Company to maintain certain financial ratios. For the current reporting period, the Company was required to maintain a leverage ratio that did not exceed 3.75x. The Company was in compliance with all covenants as of March 31, 2026 and December 31, 2025.

**Shareholder loans**

As of March 31, 2026 and December 31, 2025, there were subordinated shareholder loans totaling CHF13.6 million (2026: $17.0 million, 2025: $17.1 million) and EUR15.0 million (2026: $17.2 million, 2025: $17.6 million) from PCS Holding AG, as well as CHF10.0 million (2026: $12.5 million, 2025: $12.6 million) and EUR10.0 million (2026: $11.5 million, 2025: $11.8 million) from Gebuka AG.

Page 31 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

The loans are originally granted for a fixed term, but the term will be extended if the loan agreement is not terminated 90 days prior to the end date or if an extension agreement is signed. The change in the loan balance as of March 31, 2026 and December 31, 2025, is solely due to foreign exchange rate fluctuations. These shareholder loans were renewed and amended in connection with the New Credit Facilities Agreement.

**Other debt**

In the first quarter of 2026, the Company entered into an uncommitted revolving credit facility with a maximum availability of $20.0 million and maturity date February 9, 2027. The facility bears interest at variable rates based on applicable reference rates (e.g., SOFR, SARON or EURIBOR) plus a margin. The average interest rate for the three months ended March 31, 2026 was 5.923%. The agreement includes customary terms and conditions, including representations and warranties, events of default and covenants typical for facilities of this nature. The lender may cancel the facility any time on short notice. As of March 31, 2026, there was $20.0 million outstanding under the facility. This debt is included in "Other debt" in the table above.

*Contingent Liabilities*

Changes in Aebi Schmidt's warranty liability during the three-month periods ended March 31, 2026 and 2025 were as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| *(in thousands)* | **2026** | **2025** |
| Balance of warranty liability, beginning of period | $20303 | $10205 |
| Accruals for current period sales | 1481 | 1265 |
| Cash settlements | (1576) | (546) |
| Changes in liability for pre-existing warranties | (262) | (8) |
| Translation adjustment | (212) | 289 |
| **Balance of warranty liability, end of period** | $**19734** | $**11205** |

---

Aebi Schmidt's long-term warranty provisions amounting to $2.6 million and $1.8 million for the three-month periods ended March 31, 2026 and 2025, respectively, are included within other non-current liabilities on its Condensed Consolidated Balance Sheet.

*Contractual and Other Obligations*

Aebi Schmidt is party to contractual and other material obligations (including any material cash obligations) involving commitments to make payments to third parties, and such commitments require a material amount of cash. As part of its normal course of business, Aebi Schmidt enters into contracts with suppliers for purchases of certain raw materials, components, and services to facilitate adequate supply of these materials and services. These arrangements may contain fixed or minimum quantity purchase requirements.

Refer to Note 7 – Commitments and Contingent Liabilities to Aebi Schmidt's unaudited condensed consolidated financial statements for details on its cash obligations.

*Off-Balance Sheet Arrangements*

The contingent liabilities include guarantees amounting to $19.2 million and $20.2 million as of March 31, 2026 and December 31, 2025, respectively. Through the normal course of bidding for and executing certain projects, Aebi Schmidt has entered into bid/performance bonds and surety bonds (collectively "performance bonds") with various financial institutions. Customers can draw on such performance bonds if Aebi Schmidt does not fulfil its contractual obligations. If a performance bond is drawn, Aebi Schmidt would have an obligation to reimburse the financial institution for amounts paid. There have been no significant amounts reimbursed to financial institutions under these types of arrangements for the three months ended March 31, 2026 and 2025.

Page 32 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

**Critical Accounting Policies and Estimates**

There have been no changes to our critical accounting policies during the three months ended March 31, 2026. Refer to the Company's Form 10-K for a summary of our policies.

**Item 3.&nbsp;&nbsp;&nbsp;&nbsp;Quantitative and Qualitative Disclosures About Market Risk.**

Aebi Schmidt is exposed to market risks in the ordinary course of business, which primarily relate to fluctuations in foreign currency exchange and commodity prices. Since December 31, 2025, there have been no material changes in our foreign currency exposures, which is incorporated herein by reference, commodity prices, or interest rates. For a discussion of our exposure to market risk, refer to "*Quantitative and Qualitative Disclosures about Market Risk*" in the Form 10-K, which is incorporated herein by reference.

**Item 4.&nbsp;&nbsp;&nbsp;&nbsp;Controls and Procedures.**

**<u>Evaluation of Disclosure Controls and Procedures</u>**

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report. Based on that evaluation as of March 31, 2026, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective due to the material weaknesses in internal control over financial reporting described below.

**Previously Identified Material Weakness in Internal Control over Financial Reporting**

As previously disclosed in Aebi Schmidt's Annual Report on Form 10-K for the year ended December 31, 2025, management identified material weaknesses in internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of Aebi Schmidt's annual or interim consolidated financial statements will not be prevented or detected on a timely basis.

Aebi Schmidt's management identified the following material weaknesses in its internal control over financial reporting:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i.A lack of designing and maintaining an effective control environment commensurate with Aebi Schmidt's financial reporting requirements due to an insufficient number of professionals with an appropriate level of internal controls and technical U.S. GAAP knowledge, experience, and training to appropriately analyze, record, and disclose accounting matters, including complex, non-routine transactions accurately and timely.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ii.A lack of maintaining formal accounting policies and procedures and designing and maintaining controls related to significant accounts and disclosures to achieve complete, accurate, and timely financial accounting, reporting, and disclosures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iii.A lack of consistently establishing appropriate authorities and responsibilities related to the segregation of duties in Aebi Schmidt's finance and accounting functions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;iv.A failure to design and maintain effective information technology ("IT") general controls over user access, change management, and segregation of duties for SAP information systems in Europe that are relevant to the preparation of its financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;v.A failure to design and maintain effective IT general controls over user access, change management, and segregation of duties for the remaining information systems that are relevant to the preparation of its financial statements.

The above control deficiencies did not result in a material misstatement to the financial statements. However, the IT general control deficiencies could affect the maintenance of effective segregation of duties, as well as the effectiveness of IT-dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports), which

Page 33 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

could result in misstatements that potentially impact all financial statement accounts and disclosures that would not be prevented or detected.

**Remediation Plan**

Aebi Schmidt's management has a remediation plan to remediate the material weaknesses and will continue to evaluate the effectiveness of these remediation efforts.

The remediation plan includes the following actions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Enhancing the Company's accounting and finance organization by hiring additional personnel with appropriate U.S. GAAP technical accounting and SEC financial reporting requirements expertise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Providing targeted training to existing personnel on U.S. GAAP technical accounting, internal control over financial reporting, and SEC financial reporting requirements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Designing and implementing a formal financial reporting control framework, including strengthening management review controls and documentation standards.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Designing and implementing IT general and application controls for all systems that materially impact financial reporting, including user access, change management, and segregation of duties controls.

Management will continue to evaluate the effectiveness of these remediation efforts and will not consider the material weaknesses remediated until applicable controls are operational for a sufficient period, and management concludes through testing that these controls are operating effectively.

**<u>Changes in Internal Control over Financial Reporting</u>**

There have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the fiscal quarter ended March 31, 2026 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

**<u>Inherent Limitations on Effectiveness of Controls</u>**

An effective internal control system, no matter how well designed, has inherent limitations, including the possibility of human error or overriding of controls, and therefore can provide only reasonable assurance with respect to reliable financial reporting. Because of its inherent limitations, our internal control over financial reporting may not prevent or detect all misstatements, including the possibility of human error, the circumvention or overriding of controls, or fraud. Effective internal controls can provide only reasonable assurance with respect to the preparation and fair presentation of financial statements.

Page 34 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*<u>[Index](#i97252dd9126049278d8da9d2f8bc1fe5_13)</u>*

**PART II—OTHER INFORMATION**

**Item 1.&nbsp;&nbsp;&nbsp;&nbsp;Legal Proceedings.**

As of the date of this Quarterly Report, Aebi Schmidt is party, both as plaintiff or defendant, to a number of lawsuits and claims arising out of the normal conduct of its businesses. Aebi Schmidt's management does not currently expect its financial position, future operating results or cash flows to be materially affected by the final outcome of these legal proceedings.

**Item 1A.&nbsp;&nbsp;&nbsp;&nbsp;Risk Factors.**

We have included in Part I, Item 1A of the Form 10-K for the year ended December 31, 2025, a description of certain risks and uncertainties that could affect our business, future performance or financial condition (the "Risk Factors"). There have been no material changes from the disclosure provided in the Form 10-K for the year ended December 31, 2025 with respect to the Risk Factors. Investors should consider the Risk Factors prior to making an investment decision with respect to our stock.

**Item 2.&nbsp;&nbsp;&nbsp;&nbsp;Unregistered Sales of Equity Securities and Use of Proceeds.**

The Company did not make any unregistered sales of equity securities during the first quarter of 2026.

**Item 5.&nbsp;&nbsp;&nbsp;&nbsp;Other Information.**

<u>Rule 10b5-1</u>

During the quarter ended March 31, 2026, no director or officer (as defined in Rule 16a-1(f) under the Exchange Act) of the Company adopted, modified or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" (as each term is defined in Item 408 of Regulation S-K).

Page 35 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*[Index](#i97252dd9126049278d8da9d2f8bc1fe5_7)*

**Item 6.&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Exhibits</u>. The following exhibits are filed as a part of this Quarterly Report on Form 10-Q:

---

| | |
|:---|:---|
| Exhibit No. | **Document** |
| <u>[31.1](aebi-20260331xex311.htm)</u> | <u>[Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act](aebi-20260331xex311.htm)</u> |
| <u>[31.2](aebi-20260331xex312.htm)</u> | <u>[Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act](aebi-20260331xex312.htm)</u> |
| <u>[32](aebi-20260331xex32.htm)</u> | <u>[Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act](aebi-20260331xex32.htm)</u> |
| 101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |

---

Page 36 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

------

*[Index](#i97252dd9126049278d8da9d2f8bc1fe5_7)*

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: May 14, 2026 | **Aebi Schmidt Holding AG** | **Aebi Schmidt Holding AG** |
|  | By: | <u>/s/ Barend Fruithof</u> |
|  | Name: | Barend Fruithof |
|  | Title: | Group CEO |
|  | By: | <u>/s/ Marco Portmann</u> |
|  | Name: | Marco Portmann |
|  | Title: | Group CFO |

---

Page 37 of [39](#i465ca4a848cb4a2f8ce7d1bfb7075082_202)

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION BY THE GROUP CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Barend Fruithof, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Aebi Schmidt Holding AG;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)[Omitted in accordance with Rule 15d-14(a) of the Securities Exchange Act of 1934];

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

------

---

| | |
|:---|:---|
| Date: May 14, 2026 | |
| | /s/ Barend Fruithof |
| | Barend Fruithof |
| | Group Chief Executive Officer (Principal Executive Officer) |
| | Aebi Schmidt Holding AG |

---

## Exhibit 31.2

**EXHIBIT 31.2**

**CERTIFICATION BY THE GROUP CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Marco Portmann, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Aebi Schmidt Holding AG;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)[Omitted in accordance with Rule 15d-14(a) of the Securities Exchange Act of 1934];

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

------

---

| | |
|:---|:---|
| Date: May 14, 2026 | |
| | /s/ Marco Portmann |
| | Marco Portmann |
| | Group Chief Financial Officer (Principal Financial Officer) |
| | Aebi Schmidt Holding AG |

---

## Ex-32

**EXHIBIT 32**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**AND CHIEF FINANCIAL OFFICER**

**PURSUANT TO**

**18 U.C.S. SECTION 1350**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Each of the undersigned hereby certifies in his capacity as an officer of Aebi Schmidt Holding AG (the "Company"), pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350 that, to their knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Quarterly Report on Form 10-Q of the Company for the period ended March 31, 2026 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition at the end of such period and results of operations of the Company for such period.

------

---

| | |
|:---|:---|
| Dated: May 14, 2026 | |
| | /s/ Barend Fruithof |
| | Barend Fruithof |
| | Group Chief Executive Officer |
| | (Principal Executive Officer) |
| | /s/ Marco Portmann |
| | Marco Portmann |
| | Group Chief Financial Officer |
| | (Principal Financial Officer) |

---

<br>